{"filings":[{"id":582038,"accession_number":"0001193125-26-234426","cik":1833769,"company_name":"Hyperfine, Inc.","ticker":"HYPR","form_type":"8-K","filed_at":"2026-05-21T20:11:58+00:00","items":["5.07"],"status":"ready","headline":"Hyperfine shareholders reelect four directors, ratify Grant Thornton as auditor","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All four director nominees reelected with over 99% of votes cast (excluding broker non-votes).","Appointment of Grant Thornton LLP as auditor for FY 2026 ratified with 345.7M for, 3.7M against.","Quorum of ~89.9% of voting power present; 44.6M Class A and 15.1M Class B shares represented.","Broker non-votes of ~30.0M shares on director election; none on auditor ratification."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"market_cap_usd":155854433.2075472,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":40241,"accession_number":"0001193125-26-219380","cik":1833769,"company_name":"Hyperfine, Inc.","ticker":"HYPR","form_type":"8-K","filed_at":"2026-05-12T20:06:08+00:00","items":["2.02","9.01"],"status":"ready","headline":"Hyperfine Q1 revenue $3.9M (+83% YoY); net loss narrows to $0.09/share","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $3.90M (+83% YoY); sold 10 commercial Swoop systems vs 6 in Q1 2025.","Gross margin improved to 51% from 41%; net loss $8.62M ($0.09/sh) vs $9.42M ($0.12/sh).","R&D down 24% to $3.85M; FY 2026 revenue guidance $20-22M, cash burn $26-28M.","Received CE Marking and UKCA approval for next-gen Swoop system and Optive AI software.","$15M debt financing extends cash runway into 2028; India launch at AIIMS New Delhi."],"consensus_eps_estimate":-0.0918,"consensus_eps_actual":-0.09,"consensus_revenue_estimate":null,"consensus_revenue_actual":3903000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl+finnhub","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":155854433.2075472,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":109505,"accession_number":"0001193125-26-113996","cik":1833769,"company_name":"Hyperfine, Inc.","ticker":"HYPR","form_type":"8-K","filed_at":"2026-03-18T23:59:59+00:00","items":["1.01","2.03","3.02","9.01"],"status":"ready","headline":"Hyperfine secures up to $40M debt facility from Horizon Technology Finance; borrows $15M at close","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Borrowed $15M at closing on March 18, 2026; additional $25M available through Dec 31, 2027.","Interest rate: prime + 4.25% with a floor of 6.50% (minimum 10.75% per annum).","Interest-only payments for 48 months; potential extension to interest-only through maturity (March 18, 2031).","Issued warrants for up to 1,083,335 shares at $1.20/share (562,500 initial warrants exercisable immediately).","Commitment fee of $400,000; final payment equal to 5% of original principal; prepayment premiums from 1% to 3%."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":155854433.2075472,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":109504,"accession_number":"0001193125-26-113960","cik":1833769,"company_name":"Hyperfine, Inc.","ticker":"HYPR","form_type":"8-K","filed_at":"2026-03-18T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Hyperfine reports Q4 revenue up 128% YoY to $5.29M; guides FY2026 revenue $20-22M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 2025 revenue $5.29M (128% YoY); net loss $5.91M ($0.06/share) vs $10.39M ($0.14) prior year.","Full-year 2025 revenue $13.56M (+5.2% YoY); net loss $35.57M ($0.43/share) vs $40.72M ($0.56).","Cash $35.09M at Dec 31, 2025; secured $40M term loan in Mar 2026 ($15M initial, $25M milestone-based).","FY2026 guidance: revenue $20-22M (~55% growth at midpoint); cash burn $26-28M (~10% decline).","FDA cleared Optive AI software; Gates Foundation grant $3.7M; cash runway expected into 2028."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":155854433.2075472,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":109503,"accession_number":"0001193125-26-009859","cik":1833769,"company_name":"Hyperfine, Inc.","ticker":"HYPR","form_type":"8-K","filed_at":"2026-01-12T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Hyperfine reports preliminary Q4 revenue ~$5.3M (+127% YoY), FY revenue ~$13.5M (+5% YoY)","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 2025 revenue ~$5.3M (record quarter), +127% YoY and +54% sequential.","Full year 2025 revenue ~$13.5M, up 5% from prior year.","Cash and cash equivalents ~$35.1M as of December 31, 2025.","Net cash burn Q4 ~$5.7M (-30% YoY); full year ~$29.9M (-22% YoY).","CEO cites success across all verticals, next-gen Swoop System and Optive AI launches."],"consensus_eps_estimate":-0.0816,"consensus_eps_actual":-0.43,"consensus_revenue_estimate":null,"consensus_revenue_actual":13563000.0,"consensus_period":"2025-FY","consensus_source":"xbrl+finnhub","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":155854433.2075472,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":126014,"accession_number":"0001193125-25-335370","cik":1833769,"company_name":"Hyperfine, Inc.","ticker":"HYPR","form_type":"8-K","filed_at":"2025-12-29T23:59:59+00:00","items":["1.01","8.01","9.01"],"status":"ready","headline":"Hyperfine enters $50M at-the-market equity facility; adds BTIG as sales agent","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Amended ATM agreement allows sale of up to $50M in Class A common stock through B. Riley and BTIG.","BTIG added as additional agent; commission of 3.0% of gross proceeds on sales.","Prior ATM facility terminated; 3,464,325 shares had been sold for ~$4.35M gross proceeds.","Offering made under effective S-3 shelf; company may sell shares at its discretion.","No obligation to sell any shares; agreement terminates upon sale of all placement shares or termination."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":155854433.2075472,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":126013,"accession_number":"0001193125-25-280181","cik":1833769,"company_name":"Hyperfine, Inc.","ticker":"HYPR","form_type":"8-K","filed_at":"2025-11-13T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Hyperfine Q3 revenue $3.4M (+27% QoQ); guides Q4 rev $5-6M; net loss $11.0M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 revenue $3.4M, +27% vs Q2; sold 8 commercial Swoop systems (5 next gen).","Gross margin record 53.8% (+450 bps QoQ); net loss $11.0M ($0.14/share) vs $9.2M prior Q.","Guides Q4 revenue $5-6M (midpoint +60% sequential, +137% YoY); FY25 rev $13-14M.","Cash burn FY25 expected $29-31M, 22% decline from FY24.","Launched next gen Swoop, entered neurology office, raised $20.1M in Oct 2025."],"consensus_eps_estimate":-0.1071,"consensus_eps_actual":-0.38,"consensus_revenue_estimate":null,"consensus_revenue_actual":8270000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl+finnhub","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":155854433.2075472,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":126012,"accession_number":"0001193125-25-241438","cik":1833769,"company_name":"Hyperfine, Inc.","ticker":"HYPR","form_type":"8-K","filed_at":"2025-10-16T23:59:59+00:00","items":["1.01","8.01","9.01"],"status":"ready","headline":"Hyperfine prices $17.5M public offering of 14M shares at $1.25/share","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Offering of 14,000,000 shares of Class A common stock at $1.25 per share; gross proceeds ~$17.5M.","Underwriter granted 30-day option to purchase up to 2,100,000 additional shares (15% of firm shares).","Proceeds to be used for working capital, commercial, manufacturing, and R&D activities.","Lake Street Capital Markets is sole book-runner; expected close on or about October 17, 2025.","Existing directors and executive officers subject to 60-day lock-up; company has 90-day lock-up."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":155854433.2075472,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":126011,"accession_number":"0001193125-25-240255","cik":1833769,"company_name":"Hyperfine, Inc.","ticker":"HYPR","form_type":"8-K","filed_at":"2025-10-15T23:59:59+00:00","items":["2.02","7.01","8.01","9.01"],"status":"ready","headline":"Hyperfine reports preliminary Q3 2025 revenue of $3.4M, up 27% sequentially","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Preliminary Q3 revenue ~$3.4M, up 27% from Q2; cash and equivalents ~$21.6M as of Sept 30.","Effective ASP ~$360k, up 36% sequentially; 63% of 8 commercial units sold were next gen Swoop.","Cash burn ~$5.9M, down 27% sequentially from Q2 2025.","Commercial rollout of next gen Swoop with Optive AI underway; all US hospital pipeline converted.","Full-scale office-setting launch commenced; Optive AI rollout to installed base in US, Canada, Australia, NZ."],"consensus_eps_estimate":-0.1071,"consensus_eps_actual":-0.38,"consensus_revenue_estimate":null,"consensus_revenue_actual":8270000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl+finnhub","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":155854433.2075472,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":142745,"accession_number":"0000950170-25-108030","cik":1833769,"company_name":"Hyperfine, Inc.","ticker":"HYPR","form_type":"8-K","filed_at":"2025-08-13T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Hyperfine Q2 revenue $2.7M (+26% QoQ), net loss $9.2M; FDA clearances for Optive AI and next-gen Swoop","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $2.7M, up 26% from Q1; sold 8 commercial Swoop systems vs 6 in Q1.","Net loss $9.2M ($0.12/share) vs $9.4M in Q1; gross margin 49.3%, up 800 bps QoQ.","FDA cleared Optive AI software and next-generation Swoop system; commercial rollout begun.","Completed neurology office pilot; full-scale commercial launch initiated.","FY 2025 revenue guidance: 10-20% over 2024; cash burn guided to $27-29M, down 27% YoY."],"consensus_eps_estimate":-0.1224,"consensus_eps_actual":-0.24,"consensus_revenue_estimate":null,"consensus_revenue_actual":4833000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl+finnhub","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":155854433.2075472,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":142744,"accession_number":"0000950170-25-103970","cik":1833769,"company_name":"Hyperfine, Inc.","ticker":"HYPR","form_type":"8-K","filed_at":"2025-08-06T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Hyperfine regains Nasdaq minimum bid price compliance","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Received notice from Nasdaq on Aug 6, 2025, that it has regained compliance with the $1.00 minimum bid price requirement.","Previously reported a deficiency notice on April 30, 2025, for bid price below $1.00 for 30 consecutive business days.","The Nasdaq listing matter is now closed; no further action required.","Hyperfine's Class A common stock (HYPR) continues trading on The Nasdaq Global Market."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":155854433.2075472,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":160832,"accession_number":"0001193125-25-125906","cik":1833769,"company_name":"Hyperfine, Inc.","ticker":"HYPR","form_type":"8-K","filed_at":"2025-05-23T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Hyperfine Chairperson Huennekens resigns; Wolterman appointed as Chair","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["R. Scott Huennekens resigned as Chairperson and board member, effective May 22, 2025, for personal reasons.","Huennekens' resignation was not due to any disagreement with the company.","Board reduced size from 6 to 5 members.","Daniel J. Wolterman, current board member, appointed as new Chairperson."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":155854433.2075472,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":160831,"accession_number":"0000950170-25-074355","cik":1833769,"company_name":"Hyperfine, Inc.","ticker":"HYPR","form_type":"8-K","filed_at":"2025-05-19T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Hyperfine stockholders reelect six directors and ratify Grant Thornton as auditor at 2025 annual meeting","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All six director nominees (Huennekens, Sainz, Dahldorf, Fattori, Rothberg, Wolterman) reelected with over 310M votes each.","Ratification of Grant Thornton LLP as independent auditor for FY 2025 passed with 329.4M votes for, 153K against, 1.5M abstentions.","Quorum of 90.95% of voting power was present at the May 19, 2025 annual meeting.","Broker non-votes of 17.8M shares on director election; none on auditor ratification."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.05,"calibrated_materiality_score":0.05,"market_cap_usd":155854433.2075472,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":160830,"accession_number":"0000950170-25-070340","cik":1833769,"company_name":"Hyperfine, Inc.","ticker":"HYPR","form_type":"8-K","filed_at":"2025-05-13T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Hyperfine Q1 revenue $2.1M, down 36% YoY; net loss $9.4M; guides FY25 growth 10-20%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q1 revenue $2.1M vs $3.3M YoY; sold 6 commercial Swoop systems.","Net loss $9.4M ($0.12/share) vs $9.8M ($0.14/share) YoY; gross margin 41.3%.","Guidance: H1 2025 rev ~$5-6M; FY25 revenue growth 10-20% over 2024.","Cash burn forecast $25-28M in FY25 (31% decline at midpoint); raised $6M in registered direct offering.","Submitted next-gen Swoop technology to FDA; started NEURO PMR study for neurology offices."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.12,"consensus_revenue_estimate":null,"consensus_revenue_actual":2137000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":155854433.2075472,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":160829,"accession_number":"0000950170-25-062762","cik":1833769,"company_name":"Hyperfine, Inc.","ticker":"HYPR","form_type":"8-K","filed_at":"2025-05-02T23:59:59+00:00","items":["3.01"],"status":"ready","headline":"Hyperfine receives Nasdaq deficiency notice for bid price below $1.00 for 30 days","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Nasdaq notified Hyperfine on April 30, 2025 that its closing bid price fell below $1.00 per share for 30 consecutive business days, violating Listing Rule 5450(a)(1).","Company has until October 27, 2025 (180 calendar days) to regain compliance by achieving at least $1.00 closing bid for 10 consecutive days.","If non-compliant by Oct 27, Hyperfine may transfer to Nasdaq Capital Market for an additional 180-day cure period and may consider reverse stock split.","No immediate effect on listing or trading; Common Stock continues on The Nasdaq Global Market under symbol HYPR."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":155854433.2075472,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":179032,"accession_number":"0000950170-25-040251","cik":1833769,"company_name":"Hyperfine, Inc.","ticker":"HYPR","form_type":"8-K","filed_at":"2025-03-17T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Hyperfine reports FY 2024 revenue $12.89M (up 17% YoY), net loss $40.72M; guides H1 2025 revenue ~$6M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["FY 2024 revenue $12.89M (+17% YoY); net loss $40.72M ($0.56/share) vs $44.24M loss in 2023.","Q4 2024 revenue $2.32M (down from $2.69M); 9 commercial Swoop systems sold vs 7 in Q4 2023.","Cash $37.64M at Dec 31, 2024; raised $6.0M via direct offering; cash runway expected through end of 2026.","2025 guidance: H1 revenue ~$6M; full-year revenue growth 20-30%; cash burn $25-27M (32% decline from 2024).","IAC accreditation includes ultra-low-field MRI for CMS reimbursement; CE/UKCA Mark for 9th gen software."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":155854433.2075472,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":179031,"accession_number":"0001193125-25-024326","cik":1833769,"company_name":"Hyperfine, Inc.","ticker":"HYPR","form_type":"8-K","filed_at":"2025-02-11T23:59:59+00:00","items":["1.01","8.01","9.01"],"status":"ready","headline":"Hyperfine raises $6M in registered direct offering of common stock and warrants","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Gross proceeds of $6.0M from sale of 4,511,278 shares and warrants at $1.33 per unit.","Warrants exercisable at $1.33 per share, immediately exercisable, expire in 5 years.","Offering expected to close on Feb 12, 2025; Lake Street Capital Markets as placement agent.","Proceeds to be used for working capital and general corporate purposes.","Existing cash plus offering proceeds expected to fund operations through end of 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":155854433.2075472,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":179030,"accession_number":"0001193125-25-023996","cik":1833769,"company_name":"Hyperfine, Inc.","ticker":"HYPR","form_type":"8-K","filed_at":"2025-02-11T23:59:59+00:00","items":["2.02","7.01","8.01","9.01"],"status":"ready","headline":"Hyperfine reports preliminary FY2024 revenue ~$12.9M, gross margin 46%; highlights IAC accreditation and new exec hires","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Preliminary total revenue ~$12.9M: device revenue ~$10.5M, service revenue ~$2.4M.","Preliminary gross margin ~46%; cash and equivalents ~$37.6M as of Dec 31, 2024.","IAC accreditation for ultra-low-field MRI enables CMS reimbursement for accredited facilities.","CE approval for 9th-gen AI brain imaging software; now available in 4 European languages.","Exited 2024 with 13 distribution partners and appointed two new VP roles for adoption."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.56,"consensus_revenue_estimate":null,"consensus_revenue_actual":12890000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":155854433.2075472,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":179029,"accession_number":"0000950170-25-010230","cik":1833769,"company_name":"Hyperfine, Inc.","ticker":"HYPR","form_type":"8-K","filed_at":"2025-01-29T23:59:59+00:00","items":["2.05"],"status":"ready","headline":"Hyperfine cuts 14% of workforce, expects $0.4M costs, extends cash runway to H2 2026","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Terminated approximately 14% of global workforce, predominantly in technical and internally-facing roles.","Estimates up to $0.4 million in restructuring costs, mostly cash severance, to be completed in Q1 2025.","Expects existing cash plus product sales to fund operations into second half of 2026.","Restructuring part of transition from development to commercial stage; two additional software clearances anticipated in 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":155854433.2075472,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":195707,"accession_number":"0000950170-24-125433","cik":1833769,"company_name":"Hyperfine, Inc.","ticker":"HYPR","form_type":"8-K","filed_at":"2024-11-12T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Hyperfine Q3 revenue hits record $3.64M, up 56% YoY; net loss $0.14/shr","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $3.64M (+56% YoY); gross margin 52% vs 48% in Q3 2023.","Net loss $10.33M ($0.14 per share), improved from $10.76M ($0.15) a year ago.","FY 2024 revenue guidance $14–14.5M, implying 27–31% annual growth.","Cash burn expected $37–40M for full year 2024.","CE approval received for 9th-gen AI brain imaging software; clinical data at Alzheimer's and stroke conferences."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.42,"consensus_revenue_estimate":null,"consensus_revenue_actual":10569000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":155854433.2075472,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":211977,"accession_number":"0000950170-24-093965","cik":1833769,"company_name":"Hyperfine, Inc.","ticker":"HYPR","form_type":"8-K","filed_at":"2024-08-08T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Hyperfine Q2 revenue record $3.63M, raises FY 2024 guidance to $13-16M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Record Q2 revenue $3.63M (+7.4% YoY); 13 commercial Swoop systems sold.","Gross margin improved to 49.6% vs 42.7% YoY; net loss $0.14 per share.","Raised FY 2024 revenue guidance to $13-16M (prior $12-15M), ~31% YoY growth midpoint.","Cash burn guidance unchanged at ~$40M for full year 2024.","FDA cleared 9th gen AI brain imaging software; initiated CARE PMR Alzheimer's study."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.28,"consensus_revenue_estimate":null,"consensus_revenue_actual":6926000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":155854433.2075472,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":211976,"accession_number":"0000950170-24-086057","cik":1833769,"company_name":"Hyperfine, Inc.","ticker":"HYPR","form_type":"8-K","filed_at":"2024-07-24T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Hyperfine regains Nasdaq minimum bid price compliance; closed","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Received Nasdaq deficiency notice on May 29, 2024 for bid price below $1.00 for 30 days.","On July 24, 2024, Nasdaq Staff confirmed compliance regained; matter closed.","Common stock (HYPR) continues trading on The Nasdaq Global Market."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":155854433.2075472,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":230798,"accession_number":"0000950170-24-072416","cik":1833769,"company_name":"Hyperfine, Inc.","ticker":"HYPR","form_type":"8-K","filed_at":"2024-06-12T23:59:59+00:00","items":["5.03","5.07","9.01"],"status":"ready","headline":"Hyperfine stockholders approve Class B conversion charter amendment, reelect directors","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Charter amendment adds automatic conversion of Class B common stock to Class A effective Dec 22, 2028; approved by Class A and B votes (Class B: 301.1M for, 0 against).","All six director nominees reelected: R. Scott Huennekens, Maria Sainz, John Dahldorf, Ruth Fattori, Jonathan M. Rothberg, Daniel J. Wolterman.","Ratification of Grant Thornton LLP as independent auditor for FY 2024: 330.96M for, 34.7K against.","Annual meeting quorum achieved: 92.45% voting power present (29.94M Class A shares, 15.06M Class B shares)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":155854433.2075472,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":230797,"accession_number":"0000950170-24-067303","cik":1833769,"company_name":"Hyperfine, Inc.","ticker":"HYPR","form_type":"8-K","filed_at":"2024-05-31T23:59:59+00:00","items":["3.01"],"status":"ready","headline":"Hyperfine receives Nasdaq deficiency notice for bid price below $1.00","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Closing bid price of HYPR common stock below $1.00 for 30 consecutive business days.","180-day compliance period to regain bid price requirement, ending November 25, 2024.","If not cured, Company may seek transfer to Nasdaq Capital Market for an additional 180 days.","No immediate impact on listing or trading of Common Stock under symbol 'HYPR'.","Company evaluating options to regain compliance; delisting risk if unable to cure."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":155854433.2075472,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":230796,"accession_number":"0000950170-24-058664","cik":1833769,"company_name":"Hyperfine, Inc.","ticker":"HYPR","form_type":"8-K","filed_at":"2024-05-13T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Hyperfine Q1 revenue up 25% to $3.30M; net loss narrows to $0.14/share","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $3.30M, up 25% YoY from $2.64M; 13 commercial Swoop systems sold in Q1.","Net loss $9.85M ($0.14 loss per share), improved from $12.16M loss ($0.17) in Q1 2023.","Launched 8th gen AI software; began CARE PMR Alzheimer's study; >100 patients in stroke study.","Full-year 2024 revenue guidance $12-15M; cash burn guidance ~$40M.","Gross margin $1.35M; SG&A expense down 26% YoY to $6.43M; R&D $5.57M."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.14,"consensus_revenue_estimate":null,"consensus_revenue_actual":3295000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":155854433.2075472,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":249189,"accession_number":"0000950170-24-034697","cik":1833769,"company_name":"Hyperfine, Inc.","ticker":"HYPR","form_type":"8-K","filed_at":"2024-03-21T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Hyperfine reports Q4 2023 revenue up 89% YoY to $2.69M; FY2023 net loss narrows to $44.2M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Full year 2023 revenue $11.03M (+62% YoY); Q4 revenue $2.69M (+89% YoY).","Sold 37 commercial Swoop systems in 2023 (7 in Q4).","Net loss narrowed to $44.24M ($0.62/share) from $73.16M ($1.04/share) in 2022.","Cash burn reduced from $71M in 2022 to $42M in 2023; cash $75.18M at year-end, runway into early 2026.","FY2024 revenue guidance $12-15M; Q1 2024 expected over $3M."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":155854433.2075472,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":266684,"accession_number":"0001193125-23-274593","cik":1833769,"company_name":"Hyperfine, Inc.","ticker":"HYPR","form_type":"8-K","filed_at":"2023-11-09T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Hyperfine signs $50M at-the-market equity offering agreement with B. Riley","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Hyperfine entered into an ATM Sales Agreement with B. Riley Securities for up to $50M of Class A common stock.","Commission to B. Riley is 3.0% of gross proceeds; sales subject to effectiveness of Form S-3 filed Nov 9, 2023.","Company may sell shares at its discretion from time to time with no minimum obligation; ATM sales under Rule 415.","Proceeds not specified; offering provides capital-raising flexibility with potential dilution."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":155854433.2075472,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":266683,"accession_number":"0000950170-23-062049","cik":1833769,"company_name":"Hyperfine, Inc.","ticker":"HYPR","form_type":"8-K","filed_at":"2023-11-09T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Hyperfine Q3 revenue $2.33M flat YoY; net loss narrows to $10.76M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 revenue $2.33M (vs $2.35M YoY); sold 6 commercial Swoop systems in quarter.","Gross margin improved to 48% from 29% YoY; net loss $10.76M ($0.15 loss per share) vs $13.17M ($0.19).","Nine-month revenue $8.35M (up 55% YoY); net loss $33.55M vs $60.11M.","FY 2023 guidance: revenue $11-13M; cash burn $41-44M.","Received FDA clearance for latest AI-powered software; Alzheimer's feasibility study upcoming."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.47,"consensus_revenue_estimate":null,"consensus_revenue_actual":8346000.0,"consensus_period":"2023-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":155854433.2075472,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":266682,"accession_number":"0000950170-23-051513","cik":1833769,"company_name":"Hyperfine, Inc.","ticker":"HYPR","form_type":"8-K","filed_at":"2023-10-03T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Hyperfine terminates CMO/CSO Khan Siddiqui; transitions to consultant","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Khan Siddiqui terminated as Chief Medical Officer and Chief Strategy Officer effective September 30, 2023.","Will continue as consultant at $300/hour; salary paid through separation date.","Outstanding equity awards to continue vesting during consulting period under 2021 Equity Plan.","Separation agreement includes $500 payment, standard release, and non-disparagement.","No replacement named for the dual roles."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":155854433.2075472,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":283928,"accession_number":"0000950170-23-042415","cik":1833769,"company_name":"Hyperfine, Inc.","ticker":"HYPR","form_type":"8-K","filed_at":"2023-08-14T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Hyperfine Q2 2023 revenue $3.38M (record); net loss $10.64M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue of $3.38M vs $1.53M in Q2 2022; sold 14 commercial Swoop systems.","Net loss of $10.64M ($0.15 per share) improved from $23.16M ($0.33) a year ago.","Gross margin positive $1.44M vs negative $(0.17)M in Q2 2022.","Operating expenses reduced: R&D $5.33M, SG&A $7.81M vs $7.27M and $15.76M YoY.","Full-year 2023 guidance: revenue $10-14M, cash burn $40-45M."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.32,"consensus_revenue_estimate":null,"consensus_revenue_actual":6016000.0,"consensus_period":"2023-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":155854433.2075472,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":283927,"accession_number":"0000950170-23-033349","cik":1833769,"company_name":"Hyperfine, Inc.","ticker":"HYPR","form_type":"8-K","filed_at":"2023-07-18T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Hyperfine promotes Tom Teisseyre to COO; CMO/CSO Siddiqui moves to part-time","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Tom Teisseyre (formerly CPO) appointed COO effective July 24, 2023; base salary $425K, target bonus 50%, option grant of 200K shares.","Khan Siddiqui transitions to 20% part-time CMO/CSO; salary reduced to $87,360/year; removed from Severance Plan.","Severance Plan amended to remove Siddiqui; remaining participants include CEO, CFO, and Teisseyre.","Teisseyre will oversee product design, clinical science, operations, cybersecurity, and technical service."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"market_cap_usd":155854433.2075472,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":303517,"accession_number":"0000950170-23-027473","cik":1833769,"company_name":"Hyperfine, Inc.","ticker":"HYPR","form_type":"8-K","filed_at":"2023-06-12T23:59:59+00:00","items":["5.03","5.07","8.01","9.01"],"status":"ready","headline":"Hyperfine shifts board leadership to Chairperson; stockholders approve officer liability cap","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Bylaws amended to replace Executive Chairman with Chairperson; R. Scott Huennekens appointed Chairperson, Rothberg ceases as Vice Chair.","Stockholders approved Certificate of Amendment limiting officer liability under Delaware law (306M votes for, 3.6M against).","Directors Huennekens, Rothberg, Sainz, Dahldorf, Fattori, Wolterman reelected; Grant Thornton LLP ratified as auditor.","Nonemployee director compensation revised: Chairperson gets $40k annual cash retainer; annual equity grant changed to options for 112k shares.","Special one-time option grants: Dahldorf, Fattori, Wolterman each get 85k options at $1.97; Huennekens gets 237k options in exchange for cancellation of prior grant."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":155854433.2075472,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":303516,"accession_number":"0000950170-23-021283","cik":1833769,"company_name":"Hyperfine, Inc.","ticker":"HYPR","form_type":"8-K","filed_at":"2023-05-11T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Hyperfine Q1 revenue $2.64M record; net loss narrows to $0.17/share","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $2.64M, up 75% YoY from $1.51M; record quarterly revenue.","Net loss $12.16M ($0.17 per share) vs $23.78M ($0.34) in Q1 2022.","Gross margin improved to $1.16M from $0.08M; R&D and SG&A expenses declined.","Installed 10 commercial Swoop systems in Q1 2023.","FY 2023 guidance: revenue $10-14M, cash burn $40-45M; cash runway through end of 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.17,"consensus_revenue_estimate":null,"consensus_revenue_actual":2635000.0,"consensus_period":"2023-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":155854433.2075472,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":323170,"accession_number":"0000950170-23-010592","cik":1833769,"company_name":"Hyperfine, Inc.","ticker":"HYPR","form_type":"8-K","filed_at":"2023-03-29T23:59:59+00:00","items":["4.01","9.01"],"status":"ready","headline":"Hyperfine dismisses Deloitte, appoints Grant Thornton as auditor for FY2023","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Dismissed Deloitte & Touche and appointed Grant Thornton as independent auditor for fiscal year ending Dec 31, 2023, effective March 24, 2023.","No disagreements with Deloitte during fiscal years 2021-2022 or subsequent interim period through March 24, 2023.","Two previously-disclosed material weaknesses noted: pre-combination internal controls and SPAC share classification; discussed with Audit Committee.","Deloitte authorized to respond to Grant Thornton inquiries; Deloitte's letter dated March 29, 2023 filed as Exhibit 16.1."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":155854433.2075472,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":323165,"accession_number":"0000950170-23-009062","cik":1833769,"company_name":"Hyperfine, Inc.","ticker":"HYPR","form_type":"8-K/A","filed_at":"2023-03-22T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Hyperfine reports Q4 2022 revenue $1.424M; net loss $13.059M; FY2023 revenue guidance $10-14M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 2022 revenue $1.424M vs $0.436M YoY; net loss per share $0.19 vs $2.73 YoY.","FY2022 revenue $6.814M vs $1.496M; net loss $73.164M ($1.04 per share).","Ended 2022 with $117.5M cash; expects cash burn $40-45M in 2023.","Installed 35 commercial Swoop systems in 2022; new FDA clearances and CE Mark.","2023 revenue guidance of $10-14M; management cites right-sizing and extended cash runway through 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":155854433.2075472,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":323169,"accession_number":"0000950170-23-008944","cik":1833769,"company_name":"Hyperfine, Inc.","ticker":"HYPR","form_type":"8-K","filed_at":"2023-03-21T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Hyperfine Q4 2022 revenue $1.4M, full-year $6.8M; guides FY2023 $10-14M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Full-year 2022 revenue $6.814M vs $1.496M in 2021; net loss $73.164M ($1.04 loss per share).","Q4 2022 revenue $1.424M, net loss $13.059M ($0.19 loss per share) vs year-ago $0.436M and $26.085M loss.","Cash and equivalents $117.472M at Dec 31, 2022; management extends cash runway to end of 2025.","FY2023 revenue guidance $10-14M; expected cash burn $40-45M.","Installed 35 commercial Swoop systems in 2022; received multiple FDA clearances and CE Mark."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":155854433.2075472,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":323168,"accession_number":"0000950170-23-007297","cik":1833769,"company_name":"Hyperfine, Inc.","ticker":"HYPR","form_type":"8-K","filed_at":"2023-03-10T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"Hyperfine confirms zero exposure to Silicon Valley Bank after FDIC receivership","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["FDIC appointed receiver for Silicon Valley Bank on March 10, 2023.","Hyperfine states it holds no deposits, securities, or accounts at SVB.","Company asserts no liquidity concern related to SVB failure."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":155854433.2075472,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":323167,"accession_number":"0000950170-23-003321","cik":1833769,"company_name":"Hyperfine, Inc.","ticker":"HYPR","form_type":"8-K","filed_at":"2023-02-21T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Hyperfine regains Nasdaq bid price compliance; Swoop MRI receives CE Marking in EU","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Nasdaq confirmed compliance with $1.00 minimum bid price rule on Feb 16, 2023; matter closed.","Swoop Portable MR Imaging System received CE Marking under new EU MDR regulations on Feb 21, 2023.","CE Marking allows potential future commercial expansion into European Economic Area.","Company will maintain U.S. commercial focus in 2023; EU expansion optional.","CE Marking required compliance with stringent EU MDR, including Clinical Evaluation Report."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":155854433.2075472,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":323166,"accession_number":"0001193125-23-028445","cik":1833769,"company_name":"Hyperfine, Inc.","ticker":"HYPR","form_type":"8-K","filed_at":"2023-02-08T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Hyperfine appoints Brett Hale as CAO & CFO; Alok Gupta to step down by March 31","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Brett Hale becomes CAO on Feb 13, 2023 and CFO after 2022 10-K filing; Alok Gupta exits by March 31.","Hale receives $425k base salary, 50% target bonus, $100k sign-on bonus, and 1M stock options vesting over 4 years.","Severance plan amended to include Hale; separation with ex-General Counsel Neela Paykel includes $195k pay, COBRA, and equity vesting through March 31, 2023.","Outgoing CFO Gupta notes cost initiatives extended cash runway into 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":155854433.2075472,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":341239,"accession_number":"0000950170-22-026395","cik":1833769,"company_name":"Hyperfine, Inc.","ticker":"HYPR","form_type":"8-K","filed_at":"2022-12-12T23:59:59+00:00","items":["2.05"],"status":"ready","headline":"Hyperfine cuts ~13% of workforce; expects up to $1.7M in restructuring costs","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Terminated approximately 13% of global workforce, including employees of subsidiary Liminal Sciences.","Estimated restructuring costs of up to $1.7M, mainly cash severance and fixed asset impairment.","Restructuring expected to be substantially complete in Q4 2022 and Q1 2023.","Actions aimed at reducing costs and streamlining operations."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":155854433.2075472,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":341238,"accession_number":"0000950170-22-026303","cik":1833769,"company_name":"Hyperfine, Inc.","ticker":"HYPR","form_type":"8-K","filed_at":"2022-12-09T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Hyperfine amends executive severance plan adding CEO, CFO, and two other officers","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Participants: CEO Maria Sainz, CFO Alok Gupta, CMO/CSO Khan Siddiqui, CPO Tom Teisseyre.","Non-CIC severance: base salary times multiplier, paid as salary continuation or lump sum, plus COBRA.","CIC severance: lump sum of base salary plus target bonus times CIC multiplier; full equity vesting.","Benefits conditioned on signing release and compliance with restrictive covenants; plan supersedes prior arrangements."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":155854433.2075472,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":341237,"accession_number":"0000950170-22-026302","cik":1833769,"company_name":"Hyperfine, Inc.","ticker":"HYPR","form_type":"8-K","filed_at":"2022-12-09T23:59:59+00:00","items":["3.01"],"status":"ready","headline":"Hyperfine receives Nasdaq deficiency notice for bid price below $1.00","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Nasdaq notified Hyperfine on Dec 6, 2022 that its bid price was below $1.00 for 30 straight days.","Company has 180 days, until June 5, 2023, to regain compliance by closing at $1.00+ for 10 consecutive days.","If not cured, Hyperfine may transfer to Nasdaq Capital Market for an additional 180-day cure period.","Failure to comply risks delisting; company may appeal but no guarantee of success."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":155854433.2075472,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":341236,"accession_number":"0000950170-22-026228","cik":1833769,"company_name":"Hyperfine, Inc.","ticker":"HYPR","form_type":"8-K","filed_at":"2022-12-08T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Hyperfine terminates General Counsel Neela Paykel as part of restructuring","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Employment of Neela Paykel (General Counsel, CCO, Corporate Secretary) terminated effective Dec 9, 2022.","Termination part of organizational restructuring to streamline management and reduce expenses.","Company expects to enter a separation agreement with Paykel; terms to be disclosed later."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":155854433.2075472,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":341235,"accession_number":"0001193125-22-292024","cik":1833769,"company_name":"Hyperfine, Inc.","ticker":"HYPR","form_type":"8-K","filed_at":"2022-11-23T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Hyperfine amends executive severance plan to cover only CEO","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Board amended Severance Plan effective Nov 22, 2022 to limit participation to CEO only.","Non-CIC severance: salary continuation over period equal to multiplier × 12 months.","CIC severance: lump sum of salary + target bonus × CIC multiplier, plus full equity vesting.","Severance benefits conditioned on signing release and compliance with restrictive covenants.","Terms otherwise unchanged from prior plan."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":155854433.2075472,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":341231,"accession_number":"0000950170-22-025190","cik":1833769,"company_name":"Hyperfine, Inc.","ticker":"HYPR","form_type":"8-K/A","filed_at":"2022-11-15T23:59:59+00:00","items":["3.01"],"status":"ready","headline":"Hyperfine corrects prior 8-K; confirms controlled company exemption from Nasdaq independent board requirement","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Original November 14, 2022 Form 8-K erroneously reported non-compliance with Nasdaq Majority Independent Board rule.","Company qualifies as a 'controlled company' under Nasdaq Rule 5615(c), exempting it from that requirement.","Nasdaq has withdrawn its notice of non-compliance after being informed of the controlled company status.","Company still plans to recruit and appoint an independent director.","Filed as Amendment No. 1 to the 8-K."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":155854433.2075472,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":341234,"accession_number":"0000950170-22-025062","cik":1833769,"company_name":"Hyperfine, Inc.","ticker":"HYPR","form_type":"8-K","filed_at":"2022-11-14T23:59:59+00:00","items":["3.01"],"status":"ready","headline":"Hyperfine notifies Nasdaq of non-compliance with majority independent board requirement; cure period invoked","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Effective Oct 24, 2022, director Maria Sainz may no longer be considered independent under Nasdaq Rule 5605(a)(2).","Company notified Nasdaq on Oct 24 that it is not in compliance with Majority Independent Board requirement (Rule 5605(b)(1)).","Hyperfine is relying on the cure period per Rule 5605(b)(1)(A) to regain compliance.","Company is actively searching for a qualified independent director to remedy the non-compliance."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":155854433.2075472,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":341233,"accession_number":"0000950170-22-024471","cik":1833769,"company_name":"Hyperfine, Inc.","ticker":"HYPR","form_type":"8-K","filed_at":"2022-11-10T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Hyperfine Q3 revenue $2.35M, up 533% YoY; net loss $13.2M; 10 Swoop units installed; FY22 guidance $7-8M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 2022 revenue of $2.348M vs $0.371M in Q3 2021; net loss of $13.171M ($0.19 per share).","Gross margin improved to $0.688M from negative $(0.338M) in prior year quarter.","Installed 10 commercial Swoop systems in Q3, bringing YTD total to 30 and global installed base to 100 systems.","Full-year 2022 revenue guidance of $7M to $8M; commercial unit installations expected between 35 and 45.","R&D expenses rose to $7.338M; SG&A decreased to $6.632M vs $9.614M in Q3 2021."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.85,"consensus_revenue_estimate":null,"consensus_revenue_actual":5390000.0,"consensus_period":"2022-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":155854433.2075472,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":341232,"accession_number":"0000950170-22-019337","cik":1833769,"company_name":"Hyperfine, Inc.","ticker":"HYPR","form_type":"8-K","filed_at":"2022-10-06T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Hyperfine names Maria Sainz President and CEO, effective Oct 24, 2022","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Maria Sainz appointed CEO; base salary $550,000, target bonus 90%, sign-on $125,000.","Stock option award for 3,175,000 shares vesting over 4 years.","Interim CEO Scott Huennekens becomes Executive Chairperson; $10,000/month compensation.","Board amended Severance Plan to include CEO effective Oct 1, 2022."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":155854433.2075472,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":358289,"accession_number":"0001193125-22-251269","cik":1833769,"company_name":"Hyperfine, Inc.","ticker":"HYPR","form_type":"8-K","filed_at":"2022-09-26T23:59:59+00:00","items":["5.02","5.07"],"status":"ready","headline":"Hyperfine stockholder-approved option repricing covers up to 5.5M shares; exec options repriced to market","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Option repricing covers up to 5,496,799 shares of Class A common stock held by eligible employees, including execs.","Exercise price reduced to the closing price on the effective date (expected Oct 31, 2022); no repricing for Jonathan Rothberg.","R. Scott Huennekens (Exec Chair) holds 1,424,623 options repriced at $3.28 weighted avg; Alok Gupta (CFO) 254,333 at $3.90.","Stockholders representing 84.7% of voting power approved the repricing via written consent on Sept 26, 2022.","Company states repricing not expected to have a material impact on its statement of operations."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":155854433.2075472,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":358288,"accession_number":"0000950170-22-016480","cik":1833769,"company_name":"Hyperfine, Inc.","ticker":"HYPR","form_type":"8-K","filed_at":"2022-08-10T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Hyperfine Q2 revenue up 328% YoY to $1.5M; net loss $23.2M ($0.33/shr)","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $1.533M (Q2 2022) vs $0.358M (Q2 2021); gross margin negative at ($0.165M).","Net loss $23.159M, $0.33 loss per share vs $8.80 loss per share in prior year.","Placed 9 commercial Swoop systems in Q2; total 20 YTD and 47 launch-to-date; installed base 92.","FY 2022 guidance: revenue $7-8M and 35-45 commercial unit installations expected.","Received FDA clearances for new deep-learning imaging sequences; partnered with Viz.ai for neuro ICU."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.67,"consensus_revenue_estimate":null,"consensus_revenue_actual":3042000.0,"consensus_period":"2022-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":155854433.2075472,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":"2022-08-10T23:59:59+00:00|358288"}